Abstract: Disclosed are novel imidazolylalkylcarbonyl derivatives useful as calcium channel modulators and a preparation method of the same. Also disclosed is a method for the treatment of diseases by administering the above compounds based on their inhibitory activity against calcium channel.

Abstract: The present invention provides for novel piperazinylalkylpyrazole derivatives, the preparation method thereof and the selective T-type calcium channel blocking activity thereof. Particularly, it provides a piperazinylalkylpyrazole derivative as represented by the formula set forth below or its pharmaceutically acceptable salts, and its preparation method thereof. The compound of Formula 1 is a novel piperazinylalkylpyrazole derivative, which particulary has T-type Ca2+ channel blocking effect and thus can be useful as a therapeutic agent for nerve and muscle pain.

Abstract: The present invention concerns methods for treating or preventing neurological disorders characterized by dysfunction of nicotinic acetylcholine receptors by administering 2,2,6,6-tetramethylpiperidin-4-yl heptanoate (TMPH), or a pharmaceutically acceptable salt thereof, to the patient. In another aspect, the present invention pertains to pharmaceutical compositions containing TMPH, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. In another aspect, the present invention pertains to methods for selectively inhibiting nicotinic acetylcholine receptors that lack an ?5, ?6, or ?3 subunit by contacting an effective amount of TMPH, or a pharmaceutically acceptable salt thereof, to the receptor. The method for selectively inhibiting nicotinic acethylcholine receptors that lack an ?5 subunit can be carried out in vivo or in vitro.

Abstract: The present invention concerns methods for treating or preventing neurological disorders characterized by dysfunction of nicotinic acetylcholine receptors by administering 2,2,6,6-tetramethylpiperidin-4-yl heptanoate (TMPH), or a pharmaceutically acceptable salt thereof, to the patient. In another aspect, the present invention pertains to pharmaceutical compositions containing TMPH, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. In another aspect, the present invention pertains to methods for selectively inhibiting nicotinic acetylcholine receptors that lack an ?5, ?6, or ?3 subunit by contacting an effective amount of TMPH, or a pharmaceutically acceptable salt thereof, to the receptor. The method for selectively inhibiting nicotinic acethylcholine receptors that lack an ?5 subunit can be carried out in vivo or in vitro.

Abstract: The present invention relates to a tetrahydrofuran compound having cis substituents, the derivatives thereof and a process for preparing the same, and in particular relates to a dihydrofuran-3-ylidene triflate compound having cis substituents at C2 and C5 positions prepared through Prins-type cyclization using a homopropargylic alcohol derivative as a starting material in the presence of Lewis acid catalyst, a tetrahydrofuran compound having cis substituents at C2, C3 and C5 positions prepared through the hydrolysis of triflate group in the derivatives of the dihydrofuran-3-ylidene triflate compound, and a preparation method thereof. The derivatives and the target tetrahydrofuran compound prepared according to the present invention are hydrofuran compounds with novel structures having cis substituents at C2, C3 and/or C5 positions, which are useful as a derivative for synthesizing drugs such as an antagonist for neurokinin receptor.

Abstract: A compound represented by a general formula (Ia) or (Ib) and a stereo-selective preparation method thereof using a carbonyl reductase which is separated from Kluyveromyces marxianus. The compound can be prepared by reduction of substituted ?-keto ester and can be used as an intermediate in preparing ?-lactam group antibiotics.

Abstract: Novel pyrazolopyrimidinethione compounds of formula 1: wherein R1 and R2 are independently each hydrogen atom, a C1-C6 alkyl group, or a C3-C6 cycloalkyl group, R3 is a C1-C6 alkyl group. C3-C6 cycloalkyl group or C3-C6 alkenyl group which is substituted or unsubstituted, X is O or NR4, and R4 is hydrogen atom, or a C1-C6 alkyl group, a C3-C6 cycloalkyl group or a C3-C6 alkenyl group which is unsubstituted or substituted with OH or an alkoxy group, pharmacologically acceptable salts or hydrates thereof, and preparation methods thereof are disclosed. Pharmaceutical compositions comprising the compounds are effectively used for the treatment of erectile dysfunction.

Abstract: The present invention relates to isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptors represented by the following formula (1), and its preparation method through reductive amination reaction in the presence of reducing agent, wherein R1, R2, X and n are the same as defined in the specification.

Abstract: Disclosed are a catalyst for selective catalytic reduction of nitrogen oxides and a method for preparing the same. Useful for the removal of nitrogen oxides is a catalyst prepared using spent catalysts having been absorbed with vanadium, nickel and sulfur in the hydro-desulfurization line of an oil refinery in which a catalyst for the hydro-desulfurization contains molybdenum, iron, cobalt and silicon on the alumina support in accordance with the present invention. The present catalyst can remove nitrogen oxides at a level of 90% or higher, exhibiting a 10% or more increase in efficiency of the catalyst performance. Additionally, the catalyst can increase the efficiency of spent catalyst reclamation by 250%.

Abstract: The catalyst is prepared by recycling a spent catalyst discharged from a hydro-desulfurization process of an oil refinery in which the spent catalyst comprises an alumina support with a large specific surface area impregnated with low contents of vanadium and high contents of molybdenum. The thus prepared catalyst has more excellent selective removal activity of nitrogen oxides at a high temperature window by containing suitable amounts of metal components therein as well as a better poisoning resistance to sulfur oxides, compared with the conventional catalysts.

Abstract: The present invention relates to 4,5-dihydroisoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 and D4 receptors represented by the following Formula (1), and its preparation method through reductive amination reaction in the presence of reducing agent, wherein R1, R2, X and n are the same as defined in the specification.

Abstract: Disclosed are a catalyst for selective catalytic reduction of nitrogen oxides and a method for preparing the same. The catalyst is prepared using a spent catalyst discharged from a hydro-desulfurization process of an oil refinery in which the spent catalyst comprises vanadium, nickel, molybdenum and sulfur component on alumina, and a tungsten-impregnated support. The catalyst prepared in accordance with the present invention is very advantageous in terms of excellent selective removal effect of nitrogen oxides as well as better poisoning resistance to sulfur oxides.

Abstract: The present invention relates to a novel 4,5-dihydroisoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 and D4 receptors represented by the following Formula (1), and its preparation method through reductive amination reaction in the presence of reducing agent, 1

Abstract: Disclosed is a method for preparing a catalyst for selective catalytic reduction of nitrogen oxides at high temperature window. The catalyst is prepared by recycling a spent catalyst discharged from a hydro-desulfurization process of an oil refinery in which the spent catalyst comprises an alumina support with a large specific surface area impregnated with low contents of vanadium and high contents of molybdenum. The thus prepared catalyst has more excellent selective removal activity of nitrogen oxides at a high temperature window by containing suitable amounts of metal components therein as well as a better poisoning resistance to sulfur oxides, compared with the conventional catalysts.

Abstract: Disclosed are a catalyst for selective catalytic reduction of nitrogen oxides and a method for preparing the same. The catalyst is prepared using a spent catalyst discharged from a hydro-desulfurization process of an oil refinery in which the spent catalyst comprises vanadium, nickel, molybdenum and sulfur component on alumina, and a tungsten-impregnated support. The catalyst prepared in accordance with the present invention is very advantageous in terms of excellent selective removal effect of nitrogen oxides as well as better poisoning resistance to sulfur oxides.

Abstract: A method is provided for manufacturing cleaner fuels, in which NPC (Natural Polar Compounds), naturally existing in small quantities within various petrolic hydrocarbon fractions, are removed from the petrolic hydrocarbon fractions ranging, in boiling point, from 110 to 560° C. and preferably from 200 to 400° C., in advance of catalytic hydroprocessing. The removal of NPC improves the efficiency of the catalytic process and produces environment-friendly products, such as diesel fuel with a sulfur content of 50 ppm (wt) or lower. Also, the NPC can be used to improve fuel lubricity.